Literature DB >> 29409017

Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.

Myron J Levin1,2, Guang-Yun Cai2, Katherine S Lee2, Nadine G Rouphael3, Aneesh K Mehta3, Jennifer Canniff2, Mark J Mulligan3, Adriana Weinberg1,2,4.   

Abstract

We studied the relationship between varicella-zoster virus (VZV) DNAemia and development of VZV-specific immunity after administration of live-attenuated zoster vaccine. VZV-DNAemia, detected by polymerase chain reaction (PCR), and VZV-specific effector (Teff) and memory (Tmem) T cells, was measured in 67 vaccinees. PCR was positive in 56% (9 direct, 28 nested) on day 1 and in 16% (1 direct, 10 nested) on day 14. Teff progressively increased in direct-PCR-positive vaccinees up to day 30, but Tmem did not. Conversely, Tmem, but not Teff, increased in direct-PCR-negative vaccinees on day 7. The kinetics of these immune responses and VZV DNAemia suggested that direct-PCR sample positive represented viremia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29409017      PMCID: PMC5939641          DOI: 10.1093/infdis/jix653

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  12 in total

1.  A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.

Authors:  Yu-Lung Lau; S J Rupert Vessey; Ivan S F Chan; Tsz-Leung Lee; Li-Min Huang; Chin-Yun Lee; Tzou-Yien Lin; Bee Wah Lee; Kow Kwan; Siti M Kasim; Christina Y Chan; Karen M Kaplan; Daniel J Distefano; Anna L Harmon; Amy Golie; Jonathan Hartzel; Jin Xu; Shu Li; Holly Matthews; Jerald C Sadoff; Alan Shaw
Journal:  Vaccine       Date:  2002-07-26       Impact factor: 3.641

2.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Metabolic Phenotypes of Response to Vaccination in Humans.

Authors:  Shuzhao Li; Nicole L Sullivan; Nadine Rouphael; Tianwei Yu; Sophia Banton; Mohan S Maddur; Megan McCausland; Christopher Chiu; Jennifer Canniff; Sheri Dubey; Ken Liu; ViLinh Tran; Thomas Hagan; Sai Duraisingham; Andreas Wieland; Aneesh K Mehta; Jennifer A Whitaker; Shankar Subramaniam; Dean P Jones; Alessandro Sette; Kalpit Vora; Adriana Weinberg; Mark J Mulligan; Helder I Nakaya; Myron Levin; Rafi Ahmed; Bali Pulendran
Journal:  Cell       Date:  2017-05-11       Impact factor: 41.582

Review 4.  Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections.

Authors:  Myron J Levin
Journal:  J Clin Virol       Date:  2014-10-02       Impact factor: 3.168

5.  Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.

Authors:  Adriana Weinberg; Jennifer Canniff; Nadine Rouphael; Aneesh Mehta; Mark Mulligan; Jennifer A Whitaker; Myron J Levin
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

6.  Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization.

Authors:  Duane L Pierson; Satish K Mehta; Don Gilden; Randall J Cohrs; Maria A Nagel; D Scott Schmid; Stephen K Tyring
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

7.  Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Authors:  Adriana Weinberg; Jane H Zhang; Michael N Oxman; Gary R Johnson; Anthony R Hayward; Michael J Caulfield; Michael R Irwin; James Clair; Jeffrey G Smith; Harold Stanley; Rocio D Marchese; Ruth Harbecke; Heather M Williams; Ivan S F Chan; Robert D Arbeit; Anne A Gershon; Florian Schödel; Vicki A Morrison; Carol A Kauffman; Steve E Straus; Kenneth E Schmader; Larry E Davis; Myron J Levin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

8.  Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella.

Authors:  M H Sawyer; Y N Wu; C J Chamberlin; C Burgos; S K Brodine; W A Bowler; A LaRocco; E C Oldfield; M R Wallace
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

9.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Rafael Harpaz; Ismael R Ortega-Sanchez; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2008-06-06

10.  Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia.

Authors:  Myron J Levin; Guang-Yun Cai; Michael D Manchak; Lewis I Pizer
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  5 in total

1.  Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.

Authors:  Catia T Perciani; Bashir Farah; Rupert Kaul; Mario A Ostrowski; Salaheddin M Mahmud; Omu Anzala; Walter Jaoko; Kelly S MacDonald
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

2.  Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.

Authors:  Adriana Tovar Salazar; Ashley McKhann; Huichao Chen; Ronald J Bosch; Adriana Weinberg
Journal:  AIDS Res Hum Retroviruses       Date:  2019-07-16       Impact factor: 2.205

3.  Th1 memory differentiates recombinant from live herpes zoster vaccines.

Authors:  Myron J Levin; Miranda E Kroehl; Michael J Johnson; Andrew Hammes; Dominik Reinhold; Nancy Lang; Adriana Weinberg
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

4.  Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.

Authors:  Yunfei Wang; Jialong Qi; Han Cao; Cunbao Liu
Journal:  Virol Sin       Date:  2020-08-05       Impact factor: 4.327

5.  Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Cutan Med Surg       Date:  2018-11-21       Impact factor: 2.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.